Original articleDecline of Influenza and Respiratory Viruses With COVID-19 Public Health Measures: Alberta, Canada
Abbreviations and Acronyms
Cited by (0)
Dr. Jamil N Kanji is now with the Division of Infectious Diseases, Department of Medicine Cumming School of Medicine and Department of Pathology & Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; and the Public Health Laboratory, Alberta Precision Laboratories, Calgary, Alberta, Canada.
Dr. Nelson Lee is now with the Division of Clinical Public Health, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Potential Competing Interests: Dr Lee reports nonfinancial support from Shionogi Ltd; personal fees and nonfinancial support from Janssen Pharmaceuticals and F. Hoffmann-La Roche, Sanofi Pasteur; personal fees and other from Gilead Sciences Ltd, Genetech Inc, Seqirus Inc, and Genetech Inc; and personal fees from hVIVO Ltd, Gilead Sciences Ltd, and CIDARA Ltd. Dr Doroshenko reported receiving personal fees from Sanofi Pasteur for an advisory role and research grants paid to the University of Alberta from Canadian Institutes of Health Research, Public Health Agency of Canada, Alberta Health, and University of Alberta Hospital Foundation outside the submitted work. The remaining authors report no potential competing interests.